Total (n = 120) | |
---|---|
Gender (female, %) | 56 (46.7 %) |
Age (years, median (range)) | 63.5 (20–91) |
Age (>65 years) | 57 (47.5 %) |
Etiology of SE | |
Acute symptomatic | 50 (41.7 %) |
Remote symptomatic | 44 (36.7 %) |
Progressive symptomatic | 9 (7.5 %) |
Idiopathic/cryptogenic | 17 (14.2 %) |
SE dynamics | |
Generalized convulsive SE only | 39 (32.5 %) |
Non-convulsive SE | 50 (41.7 %) |
Generalized convulsive SE evolving into non-convulsive SE | 19 (15.8 %) |
Absence SE | 1 (0.8 %) |
First episode of SE | 106 (88 %) |
Refractory SE | 28 (23.3 %) |
LOC pretreatment | |
Awake or somnolent/confused | 56 (46.7 %) |
Stuporous or comatose | 64 (53.3 %) |
Worst seizure type | |
Simple partial, CPS, absence, myoclonic | 48 (40.0 %) |
Generalized convulsive | 48 (40.0 %) |
Non-convulsive SE in coma | 24 (20.0 %) |
History of previous epilepsy | 77 (64.2 %) |
Duration of pretreatment (>1 hour) | 88 (73.3 %) |
Duration of seizure | |
>5 min, <30 min | 10 (8.3 %) |
3 min or longer, but <1 hour | 15 (12.5 %) |
1 hour or longer | 95 (79.2 %) |
Charlon’s Comorbidity index total | |
0 | 33 (27.5 %) |
1–2 | 41 (34.1 %) |
3 or more | 46 (38.4 %) |
EEG–BS | 23 (19.2 %) |
PDs | 65 (54.2 %) |
Treated on NICU | 57 (47.5 %) |
Days on NICU (median (range)) | 8 (1–125) |